CAM

Cormorant Asset Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 737.95%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+737.95%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.98B
AUM Growth
+$220M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
52
New
Increased
Reduced
Closed

Top Buys

1
+$68.6M
2
+$55M
3
+$39.2M
4
AGMB
AgomAb Therapeutics NV
AGMB
+$34.9M
5
MAZE
Maze Therapeutics
MAZE
+$33.1M

Top Sells

1
+$69.8M
2
+$36.1M
3
+$25.4M
4
PRAX icon
Praxis Precision Medicines
PRAX
+$20M
5
GHRS icon
GH Research
GHRS
+$16.5M

Sector Composition

1 Healthcare 99.34%
2 Financials 0.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASND icon
26
Ascendis Pharma A/S
ASND
$13.8B
$21.7M 1.1%
95,000
-5,000
ROIV icon
27
Roivant Sciences
ROIV
$21.6B
$20.8M 1.05%
+750,000
ANL
28
Adlai Nortye
ANL
$769M
$20.1M 1.01%
+2,897,857
TERN
29
DELISTED
Terns Pharmaceuticals
TERN
$15.8M 0.8%
+300,000
TARS icon
30
Tarsus Pharmaceuticals
TARS
$2.56B
$15.8M 0.8%
225,000
-25,000
BHVN icon
31
Biohaven
BHVN
$1.66B
$14.9M 0.75%
1,760,000
+1,750,000
CABA icon
32
Cabaletta Bio
CABA
$616M
$14.8M 0.75%
5,500,000
+1,100,000
HLXC
33
Helix Acquisition Corp III
HLXC
$225M
$13.2M 0.66%
+1,297,500
ARQT icon
34
Arcutis Biotherapeutics
ARQT
$2.68B
$10.6M 0.53%
450,000
-50,000
SNSE icon
35
Sensei Biotherapeutics
SNSE
$28.4M
$9.65M 0.49%
+306,222
CRNX icon
36
Crinetics Pharmaceuticals
CRNX
$3.75B
$9.08M 0.46%
250,000
-50,000
ZURA icon
37
Zura Bio
ZURA
$408M
$8.63M 0.43%
+1,450,000
AXSM icon
38
Axsome Therapeutics
AXSM
$12.1B
$8.45M 0.43%
50,000
-25,000
GPCR icon
39
Structure Therapeutics
GPCR
$2.8B
$8.44M 0.43%
+175,000
COGT icon
40
Cogent Biosciences
COGT
$5.97B
$7.7M 0.39%
200,000
-25,000
GLUE icon
41
Monte Rosa Therapeutics
GLUE
$1.67B
$6.58M 0.33%
+400,000
ARWR icon
42
Arrowhead Research
ARWR
$11B
$6.27M 0.32%
+100,000
PCVX icon
43
Vaxcyte
PCVX
$7.42B
$5.81M 0.29%
100,000
-25,000
AMLX icon
44
Amylyx Pharmaceuticals
AMLX
$1.6B
$4.87M 0.25%
350,000
-50,000
RLYB icon
45
Rallybio
RLYB
$76.6M
$3.59M 0.18%
+400,000
CNTX icon
46
Context Therapeutics
CNTX
$262M
$1.39M 0.07%
+529,550
ENGN icon
47
enGene Therapeutics
ENGN
$124M
– –
-4,000,000
GHRS icon
48
GH Research
GHRS
$1.65B
– –
-1,300,000
IWM icon
49
iShares Russell 2000 ETF
IWM
$78.3B
– –
0
JANX icon
50
Janux Therapeutics
JANX
$890M
– –
-650,000
1
2
3